Your session is about to expire
← Back to Search
Ropivacaine Continuous Infusion for Osteoarthritis
Study Summary
This trial will study how well a pain-relieving catheter works for people who have had knee-replacement surgery. The catheter will give either a large dose of medication all at once or a small continuous infusion of pain medicine.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2023 Phase 3 trial • 60 Patients • NCT05053087Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there precedents for using Ropivacaine Continuous Infusion in medical research?
"73 clinical trials are underway to study Ropivacaine Continuous Infusion, 16 of which are in the final Phase 3. Most of the trials are based in Karachi, Sindh, but there are 93 locations running trials for this treatment in total."
What conditions does Ropivacaine Continuous Infusion help alleviate?
"Ropivacaine Continuous Infusion is most typically used to numb patients during surgery. However, it has other medical applications, such as reducing pain during and after childbirth and mitigating post-operative pain."
Does this experiment only include individuals who are 50 or younger?
"The age range for patients that are eligible for this trial are between 18-89 years old. In contrast, there are 39 clinical trials for patients that are under 18 and 508 for patients 65 and older."
Is this research study actively looking for more participants?
"From the information available on clinicaltrials.gov, it appears that this trial is still actively looking for participants. The trial was originally posted on April 13th, 2022 and the most recent edit was on April 28th, 2022."
Has Ropivacaine Continuous Infusion been cleared by the FDA?
"There is some clinical data affirming Ropivacaine Continuous Infusion's efficacy, and multiple rounds of safety data, which gives it a score of 3."
Might I be eligible to help researchers by enrolling in this clinical trial?
"Sixty individuals suffering from osteoarthritis will be recruited for this clinical trial, with patients' ages ranging from 18 to 89 years old. To be eligible, patients must meet the following requirements: They must be between 18 and 90 years old, willing to comply with the study's procedures, and have a diagnosis of osteoarthritis that would indicate the need for a total knee arthroplasty."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger